Grass pollen allergen extract (Oralair®)

Assessment Status Assessment process complete
Drug Grass pollen allergen extract
Brand Oralair®
Indication For the treatment of allergic grass pollen rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms confirmed by a positive cutaneous test and/or a positive titre of the specific IgE to the grass pollen.
Assessment Process
Rapid review commissioned 26/09/2011
Rapid review completed 03/10/2011
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended.